Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Obesity and COVID-19 Infection Severity: From Pathophysiology to Clinical Implications

Version 1 : Received: 22 October 2020 / Approved: 23 October 2020 / Online: 23 October 2020 (13:28:04 CEST)

How to cite: Fayssoil, A.; De Carne De Carnavalet, M.C.; Mansencal, N.; Lofaso, F.; Davido, B. Obesity and COVID-19 Infection Severity: From Pathophysiology to Clinical Implications. Preprints 2020, 2020100493. https://doi.org/10.20944/preprints202010.0493.v1 Fayssoil, A.; De Carne De Carnavalet, M.C.; Mansencal, N.; Lofaso, F.; Davido, B. Obesity and COVID-19 Infection Severity: From Pathophysiology to Clinical Implications. Preprints 2020, 2020100493. https://doi.org/10.20944/preprints202010.0493.v1

Abstract

Obesity is a significant public health concern with higher morbidity. Obesity patients are at risk of severe COVID-19 infection and obesity is a higher risk factor for intensive Care Unit admission in COVID-19 infection. Obesity status affects lung volumes, cardiac structure and hemodynamics. Obesity is associated with a low inflammation state, endothelial dysfunction, hyperinsulinaemia and metabolic disorders. The authors review cardio-respiratory pathophysiological aspects involved in obesity and propose clinical management in obese patients infected by COVD-19.

Keywords

COVID-19; Obesity; BMI; heart; lung; severity

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.